NHS Choices
"Prostate cancer patients could be screened to detect aggressive
tumours after scientists identified a protein linked to severe forms of
the disease," reports The Daily Telegraph. The news is based on the
results of a complex laboratory study looking at a protein called
NAALADL2.
Scientists found that levels of NAALADL2 were high in prostate cancer
when compared with healthy tissue, and levels were higher in more
aggressive and more extensive prostate tumours.
Read the full NHS Choices report
